BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 30693002)

  • 1. Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis.
    Mahmud SA; Binstadt BA
    Front Immunol; 2018; 9():3168. PubMed ID: 30693002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis.
    Wu CY; Yang HY; Luo SF; Lai JH
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.
    van Wesemael TJ; Ajeganova S; Humphreys J; Terao C; Muhammad A; Symmons DP; MacGregor AJ; Hafström I; Trouw LA; van der Helm-van Mil AH; Huizinga TW; Mimori T; Toes RE; Matsuda F; Svensson B; Verstappen SM; van der Woude D
    Arthritis Res Ther; 2016 Dec; 18(1):285. PubMed ID: 27906045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
    Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
    Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of Alternative Autoantibodies Does Not Follow the Evolution of Anti-Citrullinated Protein Antibodies in Preclinical Rheumatoid Arthritis: An Analysis in At-Risk First Degree Relatives.
    Anaparti V; Smolik I; Meng X; O'Neil L; Jantz MA; Fritzler MJ; El-Gabalawy H
    Arthritis Rheumatol; 2021 May; 73(5):740-749. PubMed ID: 33538122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.
    Martínez G; Gómez JA; Bang H; Martínez-Gamboa L; Roggenbuck D; Burmester GR; Torres B; Prada D; Feist E
    Rheumatol Int; 2016 Jun; 36(6):781-91. PubMed ID: 27038800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
    Moore TL; Gillian BE; Crespo-Pagnussat S; Feller L; Chauhan AK
    Clin Exp Rheumatol; 2014; 32(5):740-6. PubMed ID: 25068682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibodies to mutated citrullinated vimentin and some associated autoantibodies in juvenile idiopathic arthritis].
    Zhang L; Ru J; Jie X; Che G; Jin X; Li X
    Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):948-51. PubMed ID: 26887552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
    Spârchez M; Miu N; Bolba C; Iancu M; Spârchez Z; Rednic S
    Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to citrullinated peptides are not associated with the rate of joint destruction in patients with a well-established diagnosis of rheumatoid arthritis.
    Nieto-Colonia AM; Santos WS; Keusseyan SP; Caldana W; Fernandes AR; Andrade LE
    Braz J Med Biol Res; 2008 Mar; 41(3):188-92. PubMed ID: 18235966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).
    Lipinska J; Lipinska S; Kasielski M; Smolewska E
    Clin Rheumatol; 2016 Nov; 35(11):2699-2706. PubMed ID: 27457366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel reactive epitope-based antigen targeted by serum autoantibodies in oligoarticular and polyarticular juvenile idiopathic arthritis and development of an electrochemical biosensor.
    Araujo GR; Fujimura PT; Vaz ER; Silva TA; Rodovalho VR; Britto-Madurro AG; Madurro JM; Fonseca JE; Silva CH; Santos PS; Mourão AF; Canhão H; Goulart LR; Gonçalves J; Ueira-Vieira C
    Immunobiology; 2016 May; 221(5):634-40. PubMed ID: 26806845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity to citrullinated type II collagen in rheumatoid arthritis.
    Yoshida M; Tsuji M; Kurosaka D; Kurosaka D; Yasuda J; Ito Y; Nishizawa T; Yamada A
    Mod Rheumatol; 2006; 16(5):276-81. PubMed ID: 17039307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of autoantibodies in the pathophysiology of rheumatoid arthritis.
    Derksen VFAM; Huizinga TWJ; van der Woude D
    Semin Immunopathol; 2017 Jun; 39(4):437-446. PubMed ID: 28451788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis.
    Pang SY; Liu HY; Huang YJ; Liu YF; Dai YM; Zeng P; Zeng HS
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on autoantibodies in rheumatoid arthritis.
    Bridges SL
    Curr Rheumatol Rep; 2004 Oct; 6(5):343-50. PubMed ID: 15355746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinuclear Antibody-Positive Juvenile Idiopathic Arthritis Despite IRAK-4 Deficiency.
    Hügle B; Händel N; Schwarz K; Borte M; Schuster V
    J Clin Immunol; 2018 May; 38(4):450-453. PubMed ID: 29707745
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
    Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
    J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. History and diagnostic value of antibodies to citrullinated proteins in rheumatoid arthritis.
    Peene I; De Rycke L; Baeten D; Hoffman I; Veys EM; De Keyser F
    Int J Immunopathol Pharmacol; 2004; 17(2):107-16. PubMed ID: 15171811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course.
    Hügle B; Hinze C; Lainka E; Fischer N; Haas JP
    Pediatr Rheumatol Online J; 2014; 12():28. PubMed ID: 25114627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.